10 Next-Gen Biologics Platforms: – FierceBiotech

Stranger in a strange land?: – Bioentrepreneur

BioWorld Today Peeks Behind the BIO Partnering Curtain – BIO 2012: – BioWorld

Innovation Over Imitation: Pharmaceutical Executive

Research Shows Proteins Could Be Customized For Better Clinical Results: BioWorld Today

Making Proteins – Interview Bassil Dahiyat and Stephen Mayo: NPR Science Friday

No Assembly Required: Engineering and Science, Caltech, Vol 4.

Caltech Prof Offers Insight Into Start-Up Success: Los Angeles Times

Protein Redesigned for Greater Stability: Chemical & Engineering News

Better Than Mother Nature: Forbes

Xencor Raises $12M For Computational Design Work: BioWorld Today

Money’s There, but hurdles Abound: Los Angeles Times

Encouraging Entrepreneurship: Chemical & Engineering News

A Kinder cure. How to spot drugs that misfire: New Scientist Magazine

Designer Enzymes: The Economist

CEO Interview, September 2001: The Wall Street Transcript

Proteins In 3-D: Signals Magazine

Preventive Medicine: By hook or crook, Xencor looks to take the mystery out of drug discovery: The Zone News

Designer Cosmetics: Biotech in Personal Care: Chemical & Engineering News

Xencor Gets Real: BioCentury

Xencor Researchers Focus on TNF-Blocking Drugs: BioWorld Today

The Protein Engineers: BioCentury

Fc Regions: Next Advance in Antibody Drug Research: BioWorld Today

The Protein Engineers: BioCentury

Xencor To Use PDA Technology To Optimize Protein In Lilly Deal: BioWorld Today

Fc Regions: Next Advance in Antibody Drug Research: BioWorld Today

Xencor Gets Real: BioCentury

More Freedom To Deal: BioCentury

Xencor to Spruce Up Pfizer Antibodies: The Pink Sheet

Building Better Proteins: The Scientist

Signs of ma(b)turity: BioCentury